About Mehta Antibiotics Private Limited
Data last updated:
Mehta Antibiotics Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2011PTC214255. Its GSTIN is 27AAHCM0920H1ZO (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹13 Lakh. It is led by directors Atul Sureshchandra Mehta and Chetan Sureshchandra Mehta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 314 Janki Centre 29 Shah Industrial Estate Off Veera Desai Road Andheri (West), Mumbai, Maharashtra, India – 400053.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.81 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹2.76 Lakh (net margin 72.4%) and EBITDA of ₹2.41 Lakh (EBITDA margin 63.3%). Revenue has grown at a compounded annual rate (CAGR) of 47% over three years and 54% over five years.
The company is associated with 1 brand: Mehta Pharmaceutical. As per MCA filings, the company has open charges of ₹20 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mehtapharma.com.
Company details
Contact details
Mehta Antibiotics Private Limited's registered office is in Mumbai, Maharashtra. Its website is mehtapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address314 Janki Centre 29 Shah Industrial Estate Off Veera Desai Road Andheri (West), Mumbai, Maharashtra, India – 400053
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mehta Antibiotics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Mehta Antibiotics operates one associated brand: Mehta Pharmaceutical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality APIs and drug intermediates for pharmaceutical applications. | mehtapharma.com |
Financials of Mehta Antibiotics Private Limited
FY 2025 filings availableMehta Antibiotics Private Limited reported revenue of ₹3.81 Lakh (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 54%. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.41 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.76 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 63.3% | ||||
| Net Profit Margin | 72.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mehta Antibiotics Private Limited, buy the company report.
Board of directors of Mehta Antibiotics Private Limited
Mehta Antibiotics has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atul Sureshchandra Mehta | Director | 01 Mar 2011 | 15 Years 7 Months | Current |
| Chetan Sureshchandra Mehta | Director | 01 Mar 2011 | 15 Years 7 Months | Current |
Peer comparison
Mehta Antibiotics Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nathan Pharma Private Limited | ₹3.87 Lakh (FY 2024) | Baddi, Himachal Pradesh, India | ||||
| Mehta Antibiotics Private Limitedthis company | ₹3.81 Lakh (FY 2025) | ₹2.76 Lakh | 72.4% | -12.0% | Mumbai, Maharashtra, India | |
| Gauri India Chemtech Private Limited | ₹3.78 Lakh (FY 2025) | -85.0% | Haridwar, Uttarakhand, India | |||
| Parabolic Research Labs Limited | ₹3.74 Lakh (FY 2022) | Chandigarh, India |
To see the full peer comparison of Mehta Antibiotics Private Limited, buy the company report.
Auditor
Mehta Antibiotics Private Limited is audited by KARDAMP SHAH& CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KARDAMP SHAH& CO | FY 2022 | 127857W |
Shareholding
The shareholding of Mehta Antibiotics Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mehta Antibiotics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Nov 2022 | 100641800 | Others | ₹10 Cr | Open | |
| 09 Mar 2018 | 100160509 | Hdfc Bank Limited | ₹10 Cr | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Mehta Antibiotics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mehta Antibiotics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mehta Antibiotics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCM0920H1ZO | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mehta Antibiotics Private Limited, buy the company report.
Recent activity
Mehta Antibiotics Private Limited has 3 board changes on record since 2011: 2 appointments and 1 cessation. The latest: Suresh Prabhudas Mehta ceased to be Director on 15 Jan 2024.
Frequently asked questions
Mehta Antibiotics is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 March 2011 (15+ years old) and is registered under CIN U74900MH2011PTC214255.
Mehta Antibiotics has 2 current directors:
- Atul Sureshchandra Mehta - Director
- Chetan Sureshchandra Mehta - Director
The latest financial statements of Mehta Antibiotics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Mehta Antibiotics is 27AAHCM0920H1ZO, registered in Maharashtra.
The CIN (Corporate Identification Number) of Mehta Antibiotics is U74900MH2011PTC214255. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mehta Antibiotics was incorporated on 01 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Mehta Antibiotics by revenue are Nathan Pharma Private Limited, Gauri India Chemtech Private Limited, Parabolic Research Labs Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Suresh Prabhudas Mehta ceased to be Director on 15 Jan 2024. Atul Sureshchandra Mehta was appointed as Director on 01 Mar 2011. Chetan Sureshchandra Mehta was appointed as Director on 01 Mar 2011.
Mehta Antibiotics can be reached through the website mehtapharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Mehta Antibiotics is at 314 Janki Centre 29 Shah Industrial Estate Off Veera Desai Road Andheri West, Mumbai, Maharashtra, India – 400053.
Mehta Antibiotics operates in the pharma industry, in the drug formulation and development segment.